Moderna

Moderna should have enough data from its late-stage trial to know whether its coronavirus vaccine works in November, CEO Stephane Bancel said Thursday.  The company could have enough data by October, but that’s unlikely, Bancel said during an interview on CNBC’s “Squawk Box.” “If the infection rate in the country were to slow down in the next weeks, it could potentially be...

Massachusetts biotech firm Moderna Inc. will produce 100 million doses of its in-development vaccine for the new coronavirus for the U.S. government, the Cambridge-based company and President Donald Trump announced Tuesday.